ED50 variation of propofol when co-administered with low dose sufentanil for intravenous anesthesia in hysteroscopic examination and treatment surgery: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900021224

Enrollment

Unknown

Registered

2019-02-02

Start date

2019-02-11

Completion date

Unknown

Last updated

2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravenous anesthesia in hysteroscopic examination or operation

Interventions

Group A:Sufentanil 0.2 ug/kg was given intravenously

Group B:Sufentanil 0.1 ug/kg was given intravenously

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients arranged to undergo hysteroscopic examination or operation under intravenous anesthesia in our hospital; 2. Aged 18 to 50 years; 3. Committed to participate this trail and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. ASA III-V; 2. Positive allergic history of anaesthetic; 3. Liver or kidney dysfunction or other systemic complications before operation.

Design outcomes

Primary

Measure	Time frame
Median effective dose;	—

Secondary

Measure	Time frame
Respiratory depression incidence;Duration time given initial dose of propofol;Total amount of drugs;Ratio of total propofol to operation time;Recovery time;	—

Countries

China

Contacts

Public ContactYu Jin

Chongqing Health Center for Women and Children

dodoes@qq.com+86 18623117820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026